KronoLife Bronze Medal, 49th Geneva International Exhibition of Inventions, Switzerland
KronoLife proudly received the Bronze Medal at the Geneva International Exhibition of Inventions, one of the world’s most prestigious innovation platforms, held in Geneva, Switzerland.
The award recognizes KronoLife’s longevity innovation in cosmeceuticals, developed to address the root causes of cellular aging. The awarded innovation centers on ReverZase™, a bioactive derived from Thai herbal sources, designed to target senescent or Zombie cells, a key mechanism of the aging process.
Developed under the Evidence-First Longevity framework, ReverZase™ connects biological mechanisms with measurable and explainable outcomes. It supports the reduction of age-related inflammation, DNA protection, mitochondrial function restoration, and stimulation of collagen and hyaluronic acid synthesis for structured skin rejuvenation.
To enhance stability and delivery efficiency, KronoLife integrates nanoencapsulation technology in a Liponiosome system, improving skin penetration and preserving bioactive performance.
Clinical evaluations confirmed the product to be non-irritating, with visible improvements in skin brightness and hydration within 14 days, and enhanced smoothness, elasticity, and wrinkle reduction within 56 days. Additional protection against UVA and UVB radiation, blue light, and PM2.5 exposure was also demonstrated.
For KronoLife, this recognition represents more than an international award. It reinforces our direction in developing longevity solutions that are explainable, measurable, and applicable in real-world skin and health innovation.
Further information about our technology, products, and partnership opportunities is available through the KronoLife website.
